ELI LILLY & Co — Director's Dealing 2012

Nov 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-10-24

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-24	Common Stock	S	10000	$50.45	Disposed	20620	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1485	Indirect
Common Stock	1475	Indirect
Common Stock	4561	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.